Oops! Something went wrong while submitting the form.
Services
Hormonal change can shift autonomic regulation in ways that are often underestimated. Oestrogen affects vascular tone and blood pressure regulation. Progesterone affects sleep architecture and ventilation. Thyroid hormone sets metabolic and cardiovascular tone. Cortisol shapes the baseline state of the autonomic nervous system. When any of these moves — through perimenopause, menopause, post-pill withdrawal, thyroid dysfunction, or another hormonal shift — autonomic symptoms often move with it.
Hormones also shape mast-cell reactivity. Oestrogen can lower the threshold at which mast cells fire; perimenopausal and menstrual fluctuations often produce mast-cell flares that look like new sensitivity or worsening allergy. Hormonal change can also pull fatigue patterns up or down independently of the autonomic picture — through thyroid status, cortisol pattern, perimenopausal sleep disruption, or the broader metabolic load that hormonal transitions carry.
The result, for people in the dysautonomia or immune pathway, is a presentation that can change shape across a menstrual cycle, that worsens through perimenopause, that flares post-partum, that produces reactive symptoms cycling with hormonal change, or that does not respond to other parts of the plan because a hormonal piece is not being addressed.
Hormone replacement therapy in this pathway is the part of the work that reads the hormonal picture inside the autonomic picture and decides what role, if any, hormonal support has in the plan. It is not a default. It is one tool, used where the picture supports it.
This service is for people in the dysautonomia pathway whose autonomic symptoms appear to track with hormonal change — cyclical worsening, perimenopausal change, post-partum shift, post-pill change, or thyroid pattern. It is also for people in or approaching menopause whose autonomic management is being limited by hormonal symptoms running alongside.
The consultation maps the hormonal picture against the autonomic and immune picture. Cycle pattern where relevant, perimenopausal or menopausal status, post-partum context, previous hormonal contraception, thyroid history, current medications, mast-cell triggers and pattern, and the autonomic and reactive symptoms that are tracking against them.
Where bloodwork is the right next step, that is named and arranged — appropriate timing in the cycle for sex hormones, full thyroid panel where indicated, other endocrine investigations as the picture suggests. Where investigation will not change the management, that is named too.
A plan is built around what was found. Where hormonal therapy is clinically indicated — for example, perimenopausal symptoms, primary thyroid disease, or post-surgical hormone change — that is started carefully. Where a non-hormonal management would be the better first step, that is named.
The plan is built with the rest of the biio. dysautonomia and immune team in view. Medication management, mast-cell regulation, dietetics and exercise physiology are read into the same plan so the hormonal work, the autonomic work and the immune work move together, not against each other.
Hormonal trials have a review point. Symptoms tracked are reviewed against the protocol. Doses, formulations and routes are adjusted against what the body did, not against what was expected.
Over time, the working hormonal picture stabilises. Where ongoing therapy is appropriate, the dose finds the minimum effective level and stays there. Where therapy was a bridge through a hormonal transition, it is tapered as the transition completes.
When the hormonal work is going well, the autonomic and reactive pictures become less reactive to hormonal change. Cyclical autonomic flares and mast-cell flares both ease. Perimenopausal worsening becomes manageable. Sleep, mood, energy and fatigue patterns stabilise alongside the autonomic and immune symptoms.
Hormonal therapy does not, by itself, treat dysautonomia or immune dysregulation. Both have their own drivers, only some of which are hormonal. What hormonal therapy can do, where it is clinically indicated, is take one source of destabilisation out of the picture so the rest of the work has somewhere to land.